Evidence map›Paper›PMID 41550949›Full record

ArticleFrontiers in immunology2025

Complement-mediated and direct activation of human neutrophils induced by

Joel J M Gabrili, Ângela A A Megale, Giselle Pidde, Trent M Woodruff, Denise V Tambourgi

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Localization of the Complement C1q-Binding Site onTropical medicine and infectious disease · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joel J M GabriliImmunochemistry Laboratory, Instituto Butantan, São Paulo, Brazil.
Ângela A A MegaleImmunochemistry Laboratory, Instituto Butantan, São Paulo, Brazil.
Giselle PiddeImmunochemistry Laboratory, Instituto Butantan, São Paulo, Brazil.
Trent M WoodruffSchool of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Denise V TambourgiImmunochemistry Laboratory, Instituto Butantan, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Pararamosis is an occupational inflammatory disease caused by contact with hairs of the caterpillar Methods: Neutrophils isolated from healthy donors were directly stimulated with the extract or incubated with plasma derived from whole blood treated with the extract, in the presence or absence of compstatin, a C3 inhibitor that blocks complement activation, and PMX205, a selective C5aR1 antagonist applied directly to neutrophils. We assessed neutrophil activation by measuring cytokine and chemokine secretion, myeloperoxidase and elastase release, and neutrophil extracellular trap (NET) formation. Results: Our results reveal that pararama hair extract directly activates neutrophils, enhancing pro-inflammatory mediator release and degranulation. Moreover, plasma from extract-treated human whole blood samples further potentiated neutrophil activation, which was significantly reduced by compstatin, through inhibition of C3, and by selective blockade of the C5a receptor (C5aR1). Discussion: These findings highlight the integrated role of complement in neutrophil activation, as compstatin broadly inhibited complement-dependent effects, while PMX205 demonstrated the specific contribution of the C5a-C5aR1 axis. Targeting complement thus emerges as a promising strategy to mitigate inflammation and tissue damage in affected individuals.

Indexed as

Complement ActivationComplement System ProteinsLepidopteraNeutrophil ActivationNeutrophilsCytokinesExtracellular TrapsHumansReceptor, Anaphylatoxin C5aComplement System ProteinsCytokinesReceptor, Anaphylatoxin C5acomplementcomplement-targeted therapyinflammationinnate immunityjoint diseaseneutrophilspararamosis

Identifiers

PMID41550949
PMCPMC12807961

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.